glp 1 and blindness π Optometrists are warning GLP-1 drugs may pose these types of rare risks π β¬οΈ Details in comments glp 1 drugs blindness Exploring
Description
A.JornayvazF
In October 2025 Lilly announced plans to invest more than $1 billion to India contract manufacturing partners, aiming to leverage Indias skilled workforce and established contract manufacturing infrastructure to support Lillys growing global demand
However, medications that rely on a rapid onset, like fast-acting pain relievers, might take longer to work because of the delayed gastric emptying
GLP-1 receptor agonists , including semaglutide and tirzepatide, are a class of medications originally developed for type 2 diabetes management
What a Doctor May Check Before Considering GLP-1 Therapy for Liver Risk Before considering GLP-1 therapy in a patient with fatty liver risk, a physician may review more than weight and BMI
[DOI] [PMC free article] [PubMed] 16.Nrregaard PK, Deryabina MA, Tofteng Shelton P, Fog JU, Daugaard JR, Eriksson PO, et al
